Homburger advises vVARDIS Holding AG on its successful IPO on the New York Stock Exchange
On November 13, 2026, vVARDIS Holding AG listed its Class A ordinary shares on the New York Stock Exchange (ticker symbol VVVV). vVARDIS is a Swiss healthcare company in the dental med-tech sector headquartered in Zug, Switzerland, offering non-invasive solutions for dental professionals with the Curodont brand of products. Through its IPO, at USD 18.00 per share, vVARDIS raises gross proceeds of USD 175 m (USD 201.3 m if the underwriters’ over-allotment option is exercised in full).
Goldman Sachs & Co. LLC and J.P. Morgan acted as joint bookrunning managers, and William Blair, UBS Investment Bank and Deutsche Bank Securities acted as bookrunners.
Homburger acted as issuer’s counsel in this transaction. The Homburger team was led by Dieter Gericke and Daniel Häusermann and included Estelle Piccard, Luca Ellenberger, Magdalena Stock, Jasmin Künzle and Jana Waldvogel (all Corporate / M&A, Capital Markets) as well as Reto Heuberger and Philippe Weber (both Tax).